[1] Brissot P, Loreal O. Iron metabolism and related genetic diseases: a cleared land, keeping mysteries. J Hepatol, 2016,64:505-515.
[2] Gardi C, Arezzini B, Fortino V, et al. Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells. Biochem Pharmacol, 2002, 64: 1139-1145.
[3] Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett, 2000, 480:147-150.
[4] Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem, 2001, 276: 7806-7810.
[5] Hunter HN, Fulton DB, Ganz T, et al. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem, 2002,277:37597-37603.
[6] Michels K, Nemeth E, Ganz T, et al. Hepcidin and Host Defense against Infectious Diseases. PLoS Pathog, 2015, 11: e1004998.
[7] Fujita N, Sugimoto R, Takeo M, et al. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med, 2007, 13: 97-104.
[8] Graham RM, Reutens GM, Herbison CE, et al. Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron. J Hepatol, 2008, 48: 327-334.
[9] Giannetti AM, Snow PM, Zak O, et al. Mechanism for multiple ligand recognition by the human transferrin receptor. PLoS Biol, 2003, 1: E51.
[10] Fillebeen C, Pantopoulos K. Hepatitis C virus infection causes iron deficiency in Huh7.5.1 cells. PLoS One, 2013, 8: e83307.
[11] Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 2004, 306: 2090-2093.
[12] Lim JE, Jin O, Bennett C, et al. A mutation in Sec15l1 causes anemia in hemoglobin deficit (hbd) mice. Nat Genet, 2005, 37: 1270-1273.
[13] Ashby DR, Gale DP, Busbridge M, et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int, 2009, 75: 976-981.
[14] Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet, 2006, 38: 531-539.
[15] Pietrangelo A, Dierssen U, Valli L, et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology, 2007, 132: 294-300.
[16] Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood, 2006, 108: 3204-3209.
[17] Brechard S, Tschirhart EJ. Regulation of superoxide production in neutrophils: role of calcium influx. J Leukoc Biol, 2008, 84: 1223-1237.
[18] Shin D-Y, Chung J, Joe Y, et al. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways. Blood, 2012, 119: 2523-2532.
[19] Evstatiev R, Gasche C. Iron sensing and signalling. Gut, 2012, 61: 933-952.
[20] Fiel MI, Schiano TD, Guido M, et al. Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin. Am J Clin Pathol, 2000, 113: 35-39.
[21] Miura K, Taura K, Kodama Y, et al. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology, 2008, 48: 1420-1429.
[22] Foka P, Dimitriadis A, Kyratzopoulou E, et al. A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression. Cell Mol Life Sci, 2014, 71: 4243-4258.
[23] Ma L, Zou T, Yuan Y, et al. Duodenal ferroportin is up-regulated in patients with chronic hepatitis C. PLoS One, 2014, 9: e110658.
[24] 秦源, 郭永红, 张颖, 等. 慢性丙型肝炎铁代谢的失调机制. 临床肝胆病杂志, 2015, 31: 291-294.
[25] 潘卫华, 黎映芹, 朱平安, 等. 乙型肝炎病毒携带者铁代谢与血清铁调素相关性研究. 海南医学院学报, 2014, 10: 20-23.
[26] Yonal O, Akyuz F, Demir K, et al. Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels. Dig Dis Sci, 2010, 55: 3548-3551.
[27] Jaroszewicz J, Rogalska M, Flisiak R. Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis. Biomarkers, 2008, 13: 478-485.
[28] Olmez OF, Gurel S, Yilmaz Y. Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis. Eur J Gastroenterol Hepatol, 2010, 22: 461-465.
[29] 余琳娜, 吕佳珺, 朱云珍, 等. 慢性乙型, 丙型肝炎患者肝脏铁调素表达的下调. 世界华人消化杂志, 2015, 23: 3366-3373.
[30] Wang XH, Cheng PP, Jiang F, et al. The effect of hepatitis B virus infection on hepcidin expression in hepatitis B patients. Ann Clin Lab Sci, 2013, 43: 126-134.
[31] Armitage AE, Stacey AR, Giannoulatou E, et al. Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc Natl Acad Sci USA, 2014, 111: 12187-12192.
[32] 罗光成, 易婷婷, 闫惠平, 等. 慢性乙型肝炎患者不同疾病阶段的血清细胞因子水平研究. 免疫学杂志, 2012, 28: 1065-1068.
[33] 朱涛, 陶志华, 陈晓东, 等. 乙型肝炎患者外周血中IL-6和sIL-2R含量变化及其意义. 肝胆胰外科杂志, 2006, 18: 228-229.
[34] Lustbader ED, Hann HW, Blumberg BS. Serum ferritin as a predictor of host response to hepatitis B virus infection. Science, 1983, 220: 423-425.
[35] 肖楠, 庄辉. 酒精性肝病分子发病机制的研究进展. 肝脏, 2010, 4:299-302.
[36] Ohtake T, Saito H, Hosoki Y, et al. Hepcidin is down-regulated in alcohol loading. Alcohol Clin Exp Res, 2007, 31: S2-8.
[37] Harrison-Findik DD, Klein E, Evans J, et al. Regulation of liver hepcidin expression by alcohol in vivo does not involve Kupffer cell activation or TNF-alpha signaling. Am J Physiol Gastrointest Liver Physiol, 2009, 296: G112-118.
[38] Harrison-Findik DD, Schafer D, Klein E, et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem, 2006, 281: 22974-22982. |
